Scientific Reports · 2017 · 46 citations · 51 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurodegenerationNeuroimmunologyAlzheimer DiseaseDiabetes MellitusGlycoproteomicsNeurodegenerative DiseasesNeuroinflammationAdvanced Glycation End ProductsAlzheimer Disease NeuroimmunologyEnzyme ActivityGel ElectrophoresisGlycosylation In DiseaseMacrophage MigrationNeuroinflammation In Alzheimer DiseaseNon-enzymatic Oxidation
Glucose and glucose metabolites are able to adversely modify proteins through a non-enzymatic reaction called glycation, which is associated with the pathology of Alzheimer's Disease (AD) and is a characteristic of the hyperglycaemia induced by diabetes. However, the precise protein glycation profile that characterises AD is poorly defined and the molecular link between hyperglycaemia and AD is unknown. In this study, we define an early glycation profile of human brain using fluorescent phenylboronate gel electrophoresis and identify early glycation and oxidation of macrophage migration inhibitory factor (MIF) in AD brain. This modification inhibits MIF enzyme activity and ability to stimulate glial cells. MIF is involved in immune response and insulin regulation, hyperglycaemia, oxidative stress and glycation are all implicated in AD. Our study indicates that glucose modified and oxidised MIF could be a molecular link between hyperglycaemia and the dysregulation of the innate immune system in AD.
51
George L. Ellman · Archives of Biochemistry and Biophysics · 1959 · 26.2K citations
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Shi Du Yan, Xi Chen, Jin Fu et al. · Nature · 1996 · 2K citations
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Takashi Uehara, Tomohiro Nakamura, Dongdong Yao et al. · Nature · 2006 · 902 citations